Fortino Solórzano-Santos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Fortino Solórzano-Santos has a total of 103 co-authors. Here are the top co-authors by number of shared publications:
- Gabriela Echaniz-Aviles
Centro de Investigación sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública, Cuernavaca, Morelos, México
3 shared publications Alfonso Reyes-López
Department of Clinical Research, Hospital Infantil de México Federico Gómez, Mexico City, Mexico
2 shared publicationsCarmen L. Pérez de Gante
Biomedical Research Department. Hospital Infantil de México "Federico Gómez", Secretaría de Salud, Mexico City, Mexico
2 shared publicationsChristian S. Acosta-Contreras
COVID-19 Research Laboratory
2 shared publicationsHoracio Márquez-González
Department of Clinical Research, Hospital Infantil de México Federico Gómez, Mexico City, Mexico
2 shared publicationsJorge F. Méndez-Galván
Department of Clinical Research, Hospital Infantil de México Federico Gómez, Mexico City, Mexico
2 shared publications
Latest Publications
- Open Access
- 6 November 2025
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 19 (1) , 103030
Pneumococcal meningitis in Mexico. Serotype distribution and antimicrobial resistance before and after the introduction of pneumococcal conjugate vaccines in pediatric patients. Results from the GIVEBPVac group
- 6 November 2025
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 19 (1) , 103030
Open AccessPneumococcal meningitis in Mexico. Serotype distribution and antimicrobial resistance before and after the introduction of pneumococcal conjugate vaccines in pediatric patients. Results from the GIVEBPVac group
- 8 August 2025
- Published by Cambridge University Press (CUP) in Journal of Helminthology
- Vol. 99, e92
Recognition of Toxocara canis excretion-secretion antigens in the serum of children with epilepsy. Involvement in the diagnosis of visceral larva migrans
Visceral larva migrans syndrome (VLM) is caused by L2 Toxocara canis. This parasitic disease is difficult to diagnose in humans, but specific antigen identification could allow for parasite detection. The aim of this study was to analyse antigens of different parasite developmental stages and observe their cross-reactions with antigens from other parasites to determine their importance in the diagnosis of VLM caused by T. canis. Sera from 14 children with cryptogenic epilepsy previously positive for T. canis were analysed via Western blot (WB) using T. canis excretion-secretion antigens (TESs) from distinct morphological parasite stages; cross-reactivity of these antigens with antigens from other parasites were evaluated. Children sera recognized antigens from L2 T. canis TES, mainly a protein of 24 kDa. Proteins in the medium- and high-molecular-weight ranges were also detected in the egg phase. In the adult phase, only 42.9% of analysed sera recognized a protein of high-molecular weight. Cross-reaction tests identified medium and high-molecular weight proteins, mainly from L2 of Ascaris lumbricoides and Gnathostoma binucleatum and adults of Ancylostoma caninum, but none of the proteins found had crossover with low-molecular weight proteins from Toxocara canis. Antigens in the larval morphological stage of T. canis TES were recognized in the highest percentage of the analysed sera; these antigens could be used to diagnose VLM.
- 8 August 2025
- Published by Cambridge University Press (CUP) in Journal of Helminthology
- Vol. 99, e92
Recognition of Toxocara canis excretion-secretion antigens in the serum of children with epilepsy. Involvement in the diagnosis of visceral larva migrans
Visceral larva migrans syndrome (VLM) is caused by L2 Toxocara canis. This parasitic disease is difficult to diagnose in humans, but specific antigen identification could allow for parasite detection. The aim of this study was to analyse antigens of different parasite developmental stages and observe their cross-reactions with antigens from other parasites to determine their importance in the diagnosis of VLM caused by T. canis. Sera from 14 children with cryptogenic epilepsy previously positive for T. canis were analysed via Western blot (WB) using T. canis excretion-secretion antigens (TESs) from distinct morphological parasite stages; cross-reactivity of these antigens with antigens from other parasites were evaluated. Children sera recognized antigens from L2 T. canis TES, mainly a protein of 24 kDa. Proteins in the medium- and high-molecular-weight ranges were also detected in the egg phase. In the adult phase, only 42.9% of analysed sera recognized a protein of high-molecular weight. Cross-reaction tests identified medium and high-molecular weight proteins, mainly from L2 of Ascaris lumbricoides and Gnathostoma binucleatum and adults of Ancylostoma caninum, but none of the proteins found had crossover with low-molecular weight proteins from Toxocara canis. Antigens in the larval morphological stage of T. canis TES were recognized in the highest percentage of the analysed sera; these antigens could be used to diagnose VLM.
- Open Access
- 21 December 2024
- Published by MDPI AG in Microorganisms
- Vol. 12 (12) , 2660
Trypanosoma cruzi DNA Identification in Breast Milk from Mexican Women with Chagas Disease
(1) Background: Chagas disease is a public health problem affecting nearly 2 million women of reproductive age in Latin America. From these, 4–8% can transmit the infection to the foetus through the vertical route, whereas horizontal transmission through milk during breastfeeding remains controversial. Therefore, the presence of Trypanosoma cruzi (T. cruzi) DNA in the milk of women seropositive for Chagas disease was analysed to determine whether a relationship with the infection of their children can exist. (2) Methods: 260 pairs (mother–child) from four hospitals located in rural areas endemic to T. cruzi (state of Oaxaca) were studied. The presence of anti-T. cruzi antibodies in the serum of lactating women were determined by ELISA, whereas parasitic DNA in either breast milk or newborn’s blood was identified by PCR; (3) Results: The seroprevalence of infection in lactating women was 5.76%, and the frequency of infection detected by PCR in breast milk was 1.92%, while the frequency of infection in the blood of newborns was 1.92%. Pochutla-Oaxaca presented the highest number of positive cases in both breast milk and blood. The only risk factor found was the presence of the vector in the geographical area analysed, favouring the parasite’s transmission. Overall, the results suggest a probable transmission of T. cruzi, although whether it was through breastfeeding or through the blood during delivery could not be determined. (4) Conclusions: T. cruzi DNA was identified in lactating women’s milk and newborn blood, which is probable evidence of transmission through breastfeeding; nevertheless, future studies must be performed to confirm the presence of the parasite, alive or dead.
- 21 December 2024
- Published by MDPI AG in Microorganisms
- Vol. 12 (12) , 2660
Open AccessTrypanosoma cruzi DNA Identification in Breast Milk from Mexican Women with Chagas Disease
(1) Background: Chagas disease is a public health problem affecting nearly 2 million women of reproductive age in Latin America. From these, 4–8% can transmit the infection to the foetus through the vertical route, whereas horizontal transmission through milk during breastfeeding remains controversial. Therefore, the presence of Trypanosoma cruzi (T. cruzi) DNA in the milk of women seropositive for Chagas disease was analysed to determine whether a relationship with the infection of their children can exist. (2) Methods: 260 pairs (mother–child) from four hospitals located in rural areas endemic to T. cruzi (state of Oaxaca) were studied. The presence of anti-T. cruzi antibodies in the serum of lactating women were determined by ELISA, whereas parasitic DNA in either breast milk or newborn’s blood was identified by PCR; (3) Results: The seroprevalence of infection in lactating women was 5.76%, and the frequency of infection detected by PCR in breast milk was 1.92%, while the frequency of infection in the blood of newborns was 1.92%. Pochutla-Oaxaca presented the highest number of positive cases in both breast milk and blood. The only risk factor found was the presence of the vector in the geographical area analysed, favouring the parasite’s transmission. Overall, the results suggest a probable transmission of T. cruzi, although whether it was through breastfeeding or through the blood during delivery could not be determined. (4) Conclusions: T. cruzi DNA was identified in lactating women’s milk and newborn blood, which is probable evidence of transmission through breastfeeding; nevertheless, future studies must be performed to confirm the presence of the parasite, alive or dead.
- Open Access
The exoS, exoT, exoU and exoY Virulotypes of the Type 3 Secretion System in Multidrug Resistant Pseudomonas aeruginosa as a Death Risk Factor in Pediatric Patients
The poor prognosis of infections associated with multidrug-resistant Pseudomonas aeruginosa can be attributed to several conditions of the patient and virulence factors of the pathogen, such as the type III secretion system (T3SS), which presents the ability to inject four effectors into the host cell: ExoS, ExoT, ExoU and ExoY. The aim of this study was to analyze the distribution of exo genes through multiplex polymerase chain reaction in P. aeruginosa strains isolated from patients at a third-level pediatric hospital and their relationships with clinical variables, e.g., the origin of the sample, susceptibility profile and outcome, through a multinomial logistic regression model. A total of 336 bacterial strains were obtained from cystic fibrosis (CF; n = 55) and bloodstream infection (BSI; n = 281) samples, and eleven presence (+)/absence (−) exo virulotype patterns were identified. The virulotype V3 (exoU−/exoS+/exoT+/exoY+) was observed in 64.28%, followed by V1 (exoU+/exoS−/exoT+/exoY+) with 11.60%. Additionally, V2 (exoU+/exoS−/exoT+/exoY−) was present in 11.60%, and V7 (exoU−/exoS+/exoT+/exoY−) was present in 4.17%. The remaining virulotypes (8.33%) identified were clustered in the other virulotype (OV) group (V4, V5, V6, V8, V9, V10 and V11). The clinical records of 100 patients and their outcomes were reviewed. Fifteen patients died (CF = 4; BSI = 11). V2 and V1 were the virulotypes most related to pandrug resistance (PDR), whereas the V1 relative risk of death was determined to be almost four-fold greater than that of V3, followed by V2 and OV. In summary, the virulotypes V1, V2 and CF are related to death. This study highlights the association of T3SS virulotypes with the susceptibility profile, clinical origin and their potential for predicting a poor prognosis.
Open AccessThe exoS, exoT, exoU and exoY Virulotypes of the Type 3 Secretion System in Multidrug Resistant Pseudomonas aeruginosa as a Death Risk Factor in Pediatric Patients
The poor prognosis of infections associated with multidrug-resistant Pseudomonas aeruginosa can be attributed to several conditions of the patient and virulence factors of the pathogen, such as the type III secretion system (T3SS), which presents the ability to inject four effectors into the host cell: ExoS, ExoT, ExoU and ExoY. The aim of this study was to analyze the distribution of exo genes through multiplex polymerase chain reaction in P. aeruginosa strains isolated from patients at a third-level pediatric hospital and their relationships with clinical variables, e.g., the origin of the sample, susceptibility profile and outcome, through a multinomial logistic regression model. A total of 336 bacterial strains were obtained from cystic fibrosis (CF; n = 55) and bloodstream infection (BSI; n = 281) samples, and eleven presence (+)/absence (−) exo virulotype patterns were identified. The virulotype V3 (exoU−/exoS+/exoT+/exoY+) was observed in 64.28%, followed by V1 (exoU+/exoS−/exoT+/exoY+) with 11.60%. Additionally, V2 (exoU+/exoS−/exoT+/exoY−) was present in 11.60%, and V7 (exoU−/exoS+/exoT+/exoY−) was present in 4.17%. The remaining virulotypes (8.33%) identified were clustered in the other virulotype (OV) group (V4, V5, V6, V8, V9, V10 and V11). The clinical records of 100 patients and their outcomes were reviewed. Fifteen patients died (CF = 4; BSI = 11). V2 and V1 were the virulotypes most related to pandrug resistance (PDR), whereas the V1 relative risk of death was determined to be almost four-fold greater than that of V3, followed by V2 and OV. In summary, the virulotypes V1, V2 and CF are related to death. This study highlights the association of T3SS virulotypes with the susceptibility profile, clinical origin and their potential for predicting a poor prognosis.
- Open Access
- 12 September 2023
- Published by Instituto Mexicano del Seguro Social in Gaceta Médica de México
- Vol. 159 (4) , 353-356
SARS-CoV-2 antibodies in research personnel with asymptomatic infection in the pre-vaccination stage
- 12 September 2023
- Published by Instituto Mexicano del Seguro Social in Gaceta Médica de México
- Vol. 159 (4) , 353-356
Open AccessSARS-CoV-2 antibodies in research personnel with asymptomatic infection in the pre-vaccination stage
- Open Access
- 5 September 2023
- Published by Instituto Mexicano del Seguro Social in Boletín Médico del Hospital Infantil de México
- Vol. 80 (4) , 260-264
Immunoglobulin-resistant Kawasaki disease
Background: Kawasaki disease is a systemic vasculitis that affects small and medium-sized vessels, primarily the coronary arteries. First-line treatment includes intravenous immunoglobulin (IVIG) and acetylsalicylic acid; however, 20% do not respond adequately despite treatment. We describe a case treated with etanercept after initial IVIG failure, showing a good response. Case report: A 5-year-old female was diagnosed with classic Kawasaki disease. Echocardiography and angiotomography revealed giant and fusiform aneurysms in the coronary arteries. A first dose of IVIG therapy was administered without improvement; after the second dose, the fever persisted, so etanercept was administered, and the fever subsided. There were no new lesions in medium-caliber vessels and the previously identified coronary lesions did not progress. Conclusions: The use of etanercept in Kawasaki disease has demonstrated a clinically favorable response. Controlled clinical trials of this drug are needed to establish it as a formal therapy in cases of initial IVIG failure.
- 5 September 2023
- Published by Instituto Mexicano del Seguro Social in Boletín Médico del Hospital Infantil de México
- Vol. 80 (4) , 260-264
Open AccessImmunoglobulin-resistant Kawasaki disease
Background: Kawasaki disease is a systemic vasculitis that affects small and medium-sized vessels, primarily the coronary arteries. First-line treatment includes intravenous immunoglobulin (IVIG) and acetylsalicylic acid; however, 20% do not respond adequately despite treatment. We describe a case treated with etanercept after initial IVIG failure, showing a good response. Case report: A 5-year-old female was diagnosed with classic Kawasaki disease. Echocardiography and angiotomography revealed giant and fusiform aneurysms in the coronary arteries. A first dose of IVIG therapy was administered without improvement; after the second dose, the fever persisted, so etanercept was administered, and the fever subsided. There were no new lesions in medium-caliber vessels and the previously identified coronary lesions did not progress. Conclusions: The use of etanercept in Kawasaki disease has demonstrated a clinically favorable response. Controlled clinical trials of this drug are needed to establish it as a formal therapy in cases of initial IVIG failure.
- 15 August 2023
- Published by Instituto Mexicano del Seguro Social in Gaceta Médica de México
- Vol. 159 (4) , 001-005
Anticuerpos contra SARS-CoV-2 en personal de investigación con infección asintomática en la etapa prevacunal
- 15 August 2023
- Published by Instituto Mexicano del Seguro Social in Gaceta Médica de México
- Vol. 159 (4) , 001-005
Anticuerpos contra SARS-CoV-2 en personal de investigación con infección asintomática en la etapa prevacunal
- Open Access
- 16 May 2023
- Published by MDPI AG in Antibiotics
- Vol. 12 (5) , 915
The Real Practice Prescribing Antibiotics in Outpatients: A Failed Control Case Assessed through the Simulated Patient Method
The first level of medical care provides the largest number of consultations for the most frequent diseases at the community level, including acute pharyngitis (AP), acute diarrhoea (AD) and uncomplicated acute urinary tract infections (UAUTIs). The inappropriate use of antibiotics in these diseases represents a high risk for the generation of antimicrobial resistance (AMR) in bacteria causing community infections. To evaluate the patterns of medical prescription for these diseases in medical offices adjacent to pharmacies, we used an adult simulated patient (SP) method representing the three diseases, AP, AD and UAUTI. Each person played a role in one of the three diseases, with the signs and symptoms described in the national clinical practice guidelines (CPGs). Diagnostic accuracy and therapeutic management were assessed. Information from 280 consultations in the Mexico City area was obtained. For the 101 AP consultations, in 90 cases (89.1%), one or more antibiotics or antivirals were prescribed; for the 127 AD, in 104 cases (81.8%), one or more antiparasitic drugs or intestinal antiseptics were prescribed; for the scenarios involving UAUTIs in adult women, in 51 of 52 cases (98.1%) one antibiotic was prescribed. The antibiotic group with the highest prescription pattern for AP, AD and UAUTIs was aminopenicillins and benzylpenicillins [27/90 (30%)], co-trimoxazole [35/104 (27.6%)] and quinolones [38/51 (73.1%)], respectively. Our findings reveal the highly inappropriate use of antibiotics for AP and AD in a sector of the first level of health care, which could be a widespread phenomenon at the regional and national level and highlights the urgent need to update antibiotic prescriptions for UAUTIs according to local resistance patterns. Supervision of adherence to the CPGs is needed, as well as raising awareness about the rational use of antibiotics and the threat posed by AMR at the first level of care.
- 16 May 2023
- Published by MDPI AG in Antibiotics
- Vol. 12 (5) , 915
Open AccessThe Real Practice Prescribing Antibiotics in Outpatients: A Failed Control Case Assessed through the Simulated Patient Method
The first level of medical care provides the largest number of consultations for the most frequent diseases at the community level, including acute pharyngitis (AP), acute diarrhoea (AD) and uncomplicated acute urinary tract infections (UAUTIs). The inappropriate use of antibiotics in these diseases represents a high risk for the generation of antimicrobial resistance (AMR) in bacteria causing community infections. To evaluate the patterns of medical prescription for these diseases in medical offices adjacent to pharmacies, we used an adult simulated patient (SP) method representing the three diseases, AP, AD and UAUTI. Each person played a role in one of the three diseases, with the signs and symptoms described in the national clinical practice guidelines (CPGs). Diagnostic accuracy and therapeutic management were assessed. Information from 280 consultations in the Mexico City area was obtained. For the 101 AP consultations, in 90 cases (89.1%), one or more antibiotics or antivirals were prescribed; for the 127 AD, in 104 cases (81.8%), one or more antiparasitic drugs or intestinal antiseptics were prescribed; for the scenarios involving UAUTIs in adult women, in 51 of 52 cases (98.1%) one antibiotic was prescribed. The antibiotic group with the highest prescription pattern for AP, AD and UAUTIs was aminopenicillins and benzylpenicillins [27/90 (30%)], co-trimoxazole [35/104 (27.6%)] and quinolones [38/51 (73.1%)], respectively. Our findings reveal the highly inappropriate use of antibiotics for AP and AD in a sector of the first level of health care, which could be a widespread phenomenon at the regional and national level and highlights the urgent need to update antibiotic prescriptions for UAUTIs according to local resistance patterns. Supervision of adherence to the CPGs is needed, as well as raising awareness about the rational use of antibiotics and the threat posed by AMR at the first level of care.
- Open Access
- 21 April 2023
- Published by Instituto Mexicano del Seguro Social in Gaceta Médica de México
- Vol. 159 (2) , 138-144
Spotted fever rickettsioses. Study of cases reported in a secondary care pediatric hospital of northeastern Mexico, 2012-2022
Background: Spotted fever rickettsiosis is a serious disease with a high mortality rate if not timely detected. Objective: To describe the characteristics of patients hospitalized for spotted fever rickettsiosis, as well as the risk factors associated with poor prognosis. Material and methods: Data from medical records of patients hospitalized between August 2012 and July 2022 were collected. Variables were analyzed using Mann-Whitney’s U-test, Fisher’s exact test, and univariate or multivariate logistic regression analysis. Results: Twenty-six patients were analyzed, among which a mortality of 57.6% was identified. In the between-group comparison, platelet count was lower in non-survivors (16.0 × 103/μL vs. 25.9 × 103/μL, p = 0.031). The percentage of surviving patients who received treatment more than 72 hours after fever onset was 45.5% (five patients) vs. 86.7% of non-survivors (13 patients) (p = 0.034). Receiving treatment 72 hours after fever onset increased by 7.09 times the probability of a fatal outcome (OR = 8.09, 95% CI = 1.1-55.8, p = 0.034). Conclusions: Starting adequate treatment 72 hours after the onset of fever may be an important risk factor for mortality, hence the importance of timely diagnosis and appropriate treatment of this disease.
- 21 April 2023
- Published by Instituto Mexicano del Seguro Social in Gaceta Médica de México
- Vol. 159 (2) , 138-144
Open AccessSpotted fever rickettsioses. Study of cases reported in a secondary care pediatric hospital of northeastern Mexico, 2012-2022
Background: Spotted fever rickettsiosis is a serious disease with a high mortality rate if not timely detected. Objective: To describe the characteristics of patients hospitalized for spotted fever rickettsiosis, as well as the risk factors associated with poor prognosis. Material and methods: Data from medical records of patients hospitalized between August 2012 and July 2022 were collected. Variables were analyzed using Mann-Whitney’s U-test, Fisher’s exact test, and univariate or multivariate logistic regression analysis. Results: Twenty-six patients were analyzed, among which a mortality of 57.6% was identified. In the between-group comparison, platelet count was lower in non-survivors (16.0 × 103/μL vs. 25.9 × 103/μL, p = 0.031). The percentage of surviving patients who received treatment more than 72 hours after fever onset was 45.5% (five patients) vs. 86.7% of non-survivors (13 patients) (p = 0.034). Receiving treatment 72 hours after fever onset increased by 7.09 times the probability of a fatal outcome (OR = 8.09, 95% CI = 1.1-55.8, p = 0.034). Conclusions: Starting adequate treatment 72 hours after the onset of fever may be an important risk factor for mortality, hence the importance of timely diagnosis and appropriate treatment of this disease.
- 6 October 2021
- Published by Instituto Mexicano del Seguro Social in Gaceta Médica de México
- Vol. 157 (5) , 533-538
Colonización cervicovaginal y rectal por estreptococos del grupo B en embarazadas mexicanas a término
- 6 October 2021
- Published by Instituto Mexicano del Seguro Social in Gaceta Médica de México
- Vol. 157 (5) , 533-538
Colonización cervicovaginal y rectal por estreptococos del grupo B en embarazadas mexicanas a término